An intention-to-treat analysis
failed to differentiate placebo from the
BCAA treatment, but despite the power
limitations of such a small study, there were
hints of additional benefit in the BCAA
group. For example, 4 of the 8 BCAA
patients were discharged before day 15,
compared with only 2 from the 10 in the
placebo group.